Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic (acetaminophen + ibuprofen) for postoperative pain after cardiovascular surgery
KCT0011695Phase 4Not yet recruiting
- Sponsor
- Kyongbo Pharmaceutical Co., Ltd
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acetaminophen + ibuprofen in Rheumatic Mitral Valve Disease, Rheumatic aortic valve disease (RAVD), mitral valve disease and 3 more, sponsored by Kyongbo Pharmaceutical Co., Ltd. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
Rheumatic Mitral Valve DiseaseRheumatic aortic valve disease (RAVD)mitral valve diseaseaortic valve disease (AVD)tricuspid valve disease
Beyond the preview
Go deeper on KCT0011695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011695.